...
首页> 外文期刊>Histopathology: Official Journal of the British Division of the International Academy of Pathology >Tumour parcellation and quantification (TuPaQ): a tool for refining biomarker analysis through rapid and automated segmentation of tumour epithelium
【24h】

Tumour parcellation and quantification (TuPaQ): a tool for refining biomarker analysis through rapid and automated segmentation of tumour epithelium

机译:肿瘤局部和定量(TupaQ):一种通过肿瘤上皮的快速和自动分割来精炼生物标志物分析的工具

获取原文
获取原文并翻译 | 示例

摘要

Background and aims Immunohistochemistry (IHC) is an essential component of biomarker research in cancer. Automated biomarker quantification is hampered by the failure of computational algorithms to discriminate 'negative' tumour cells from 'negative' stromal cells. We sought to develop an algorithm for segmentation of tumour epithelium in colorectal cancer (CRC), irrespective of the biomarker expression in the cells. Methods and results We developed tumour parcellation and quantification (TuPaQ) to segment tumour epithelium and parcellate sections into 'epithelium' and 'non-epithelium'. TuPaQ comprises image pre-processing, extraction of regions of interest (ROIs) and quantification of tumour epithelium (total area occupied by epithelium and number of nuclei in the occupied area). A total of 286 TMA cores from CRC were manually annotated and analysed using the commercial halo software to provide ground truth. The performance of TuPaQ was evaluated against the ground truth using a variety of metrics. The image size of each core was 7000 x 7000 pixels and each core was analysed in a matter of seconds. Pixel x pixel analysis showed a sensitivity of 84% and specificity of 95% in detecting epithelium. The mean tumour area obtained by TuPaQ was very close to the area quantified after manual annotation (r = 0.956, P < 0.001). Moreover, quantification of tumour nuclei by TuPaQ correlated very strongly with that of halo (r = 0.891, P < 0.001). Conclusion TuPaQ is a very rapid and accurate method of separating the epithelial and stromal compartments of colorectal tumours. This will allow more accurate and objective analysis of immunohistochemistry.
机译:背景和AIMS免疫组织化学(IHC)是癌症中生物标志物研究的重要组成部分。自动化生物标志物量化被计算算法失败阻碍了从“负”基质细胞中鉴别“负”肿瘤细胞的失败。我们试图开发一种用于结直肠癌(CRC)中肿瘤上皮细胞分段的算法,无论细胞中的生物标志物表达如何。方法和结果我们将肿瘤局部局部和定量(Tupaq)分段为将肿瘤上皮和静脉分段分成“上皮”和“非上皮细胞”。图帕克包括图像预处理,提取感兴趣区域(ROI)和肿瘤上皮的定量(由上皮占据的总面积和占用区域中的核数)。使用商业光环软件手动注释和分析来自CRC的286个TMA核心,以提供实践。使用各种指标对地面真理进行评估Tupaq的表现。每个核心的图像尺寸为7000 x 7000像素,并且在几秒钟内分析了每个核心。像素X像素分析显示出在检测上皮的84%和95%的特异性的灵敏度。 Tupaq获得的平均肿瘤面积非常接近手动注释后量化的区域(r = 0.956,p <0.001)。此外,TupaQ的肿瘤核定量与卤素的肿瘤核(R = 0.891,P <0.001)非常强烈地相关。结论TupaQ是分离结直肠癌上皮和基质隔室的一种非常快速和准确的方法。这将允许对免疫组织化学更准确和客观的分析。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号